Moreover, in the study performed by Lee et al. [21], patients with lower soluble α-Klotho levels had greater cerebral infarction volume and neurological deficit, and this fact seems to explain the worse 3-month outcome in their cohort. The gene discussed is KL; the disease is cerebral infarction.